DK0733065T3 - Hidtil ukendte peptider afledt fra autoantigen til anvendelse ved immunoterapi af autoimmunsygdomme - Google Patents

Hidtil ukendte peptider afledt fra autoantigen til anvendelse ved immunoterapi af autoimmunsygdomme

Info

Publication number
DK0733065T3
DK0733065T3 DK95937008T DK95937008T DK0733065T3 DK 0733065 T3 DK0733065 T3 DK 0733065T3 DK 95937008 T DK95937008 T DK 95937008T DK 95937008 T DK95937008 T DK 95937008T DK 0733065 T3 DK0733065 T3 DK 0733065T3
Authority
DK
Denmark
Prior art keywords
autoantigen
peptides
seq
pct
autoimmune diseases
Prior art date
Application number
DK95937008T
Other languages
English (en)
Inventor
Anna Maria Helena Boots
Gijsbertus Francisc Verheijden
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK0733065T3 publication Critical patent/DK0733065T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK95937008T 1994-10-27 1995-10-25 Hidtil ukendte peptider afledt fra autoantigen til anvendelse ved immunoterapi af autoimmunsygdomme DK0733065T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94203128 1994-10-27
EP95200886 1995-04-07
PCT/EP1995/004201 WO1996013517A1 (en) 1994-10-27 1995-10-25 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases

Publications (1)

Publication Number Publication Date
DK0733065T3 true DK0733065T3 (da) 1999-10-11

Family

ID=26136688

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95937008T DK0733065T3 (da) 1994-10-27 1995-10-25 Hidtil ukendte peptider afledt fra autoantigen til anvendelse ved immunoterapi af autoimmunsygdomme

Country Status (24)

Country Link
US (1) US5736507A (da)
EP (1) EP0733065B1 (da)
JP (1) JP3755894B2 (da)
KR (1) KR100485979B1 (da)
CN (1) CN1161379C (da)
AT (1) ATE177756T1 (da)
AU (1) AU696827B2 (da)
BR (1) BR9506377A (da)
CA (1) CA2173874A1 (da)
DE (1) DE69508380T2 (da)
DK (1) DK0733065T3 (da)
ES (1) ES2130672T3 (da)
FI (1) FI118472B (da)
GR (1) GR3030296T3 (da)
HK (1) HK1002012A1 (da)
HU (1) HU218027B (da)
IL (1) IL115744A (da)
MX (1) MX9602495A (da)
NO (1) NO316703B1 (da)
NZ (1) NZ295659A (da)
PL (1) PL183761B1 (da)
RU (1) RU2178797C2 (da)
TR (1) TR199501326A2 (da)
WO (1) WO1996013517A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843449A (en) * 1996-03-25 1998-12-01 Akzo Nobel N.V. Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
US6881824B1 (en) 1996-04-24 2005-04-19 Akzo Nobel N.V. Peptides suitable for use in antigen specific immunosuppressive therapy
IL120561A0 (en) 1996-04-24 1997-07-13 Akzo Nobel Nv Peptides suitable for use in immunosuppressive therapy
EP0947524A1 (en) * 1998-03-30 1999-10-06 Upither B.V. Novel peptides for the treatment of autoimmune diseases
EP1100526A2 (en) * 1998-07-23 2001-05-23 Akzo Nobel N.V. USE OF HC gp-39 IN IMMUNE DISEASES
KR20010071020A (ko) * 1998-07-23 2001-07-28 에프.지.엠. 헤르만스 ; 이.에이치. 리링크 자가 면역 질환의 면역 요법에서 사용하기 위한 신규한펩티드
AU780238B2 (en) * 1999-10-18 2005-03-10 Akzo Nobel N.V. Modified peptides and peptidomimetics for use in immunotherapy
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
HUP0400659A3 (en) * 2001-07-24 2005-06-28 Zhu Zhou Woodbridge Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
WO2005081980A2 (en) * 2004-02-25 2005-09-09 Medimmune, Inc. Methods and compositions relating to chitinases and chitinase-like molecules and modulation of osteoclasts
WO2007027748A2 (en) * 2005-08-31 2007-03-08 Medimmune, Inc. C/clp antagonists and methods of use thereof
RU2302872C9 (ru) * 2006-06-22 2008-12-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Средство, нормализующее функции хрящевой ткани, и способ его получения
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
CA2696563A1 (en) 2007-08-15 2009-02-19 Circassia Limited Peptides for vaccine
EP2153841B2 (en) 2008-08-15 2015-11-11 Circassia Limited Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
EP2331124A1 (en) * 2008-08-15 2011-06-15 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
GB2469894B (en) 2009-02-05 2011-09-07 Circassia Ltd Peptides for use in treating allergy to grass pollen
CA2778669C (en) * 2009-10-27 2019-04-16 Erytech Pharma Composition to induce specific immune tolerance
EP3344575B1 (en) 2015-09-04 2020-04-15 SQZ Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6323898A (ja) * 1986-07-16 1988-02-01 Dainippon Pharmaceut Co Ltd 新規ポリペプチド及びそれをコ−ドするｄｎａ並びにそれらの製法
IL92629A0 (en) * 1989-12-10 1990-08-31 Yeda Res & Dev Direct binding of t-cell epitopes to mhc gene products on intact living antigen presenting cells and the use thereof for identifying epitopes causing autoimmune diseases and pharmaceutical compositions for treating such diseases
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices

Also Published As

Publication number Publication date
HK1002012A1 (en) 1998-07-24
TR199501326A2 (tr) 1996-06-21
DE69508380T2 (de) 1999-09-09
KR100485979B1 (ko) 2006-01-27
NZ295659A (en) 1998-02-26
US5736507A (en) 1998-04-07
WO1996013517A1 (en) 1996-05-09
RU2178797C2 (ru) 2002-01-27
IL115744A (en) 2000-07-16
JPH09507861A (ja) 1997-08-12
FI962619A (fi) 1996-06-25
PL183761B1 (pl) 2002-07-31
HUT74847A (en) 1997-02-28
IL115744A0 (en) 1996-01-19
ES2130672T3 (es) 1999-07-01
GR3030296T3 (en) 1999-09-30
MX9602495A (es) 1997-05-31
AU3925295A (en) 1996-05-23
FI118472B (fi) 2007-11-30
BR9506377A (pt) 1997-09-16
HU218027B (hu) 2000-05-28
PL315198A1 (en) 1996-10-14
DE69508380D1 (de) 1999-04-22
AU696827B2 (en) 1998-09-17
HU9601401D0 (en) 1996-07-29
CN1161379C (zh) 2004-08-11
NO962695L (no) 1996-06-26
CA2173874A1 (en) 1996-05-09
CN1168677A (zh) 1997-12-24
NO316703B1 (no) 2004-04-13
FI962619A0 (fi) 1996-06-25
NO962695D0 (no) 1996-06-26
KR960705848A (ko) 1996-11-08
EP0733065B1 (en) 1999-03-17
ATE177756T1 (de) 1999-04-15
EP0733065A1 (en) 1996-09-25
JP3755894B2 (ja) 2006-03-15

Similar Documents

Publication Publication Date Title
DK0733065T3 (da) Hidtil ukendte peptider afledt fra autoantigen til anvendelse ved immunoterapi af autoimmunsygdomme
Ugrinovic et al. A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis.
Taneja et al. HLA class II transgenic mice as models of human diseases
ATE167062T1 (de) Verfahren zur anregung antigenspezifischer t- zelltoleranz
CY1109837T1 (el) Διαγνωστικο και θεραπευτικο επιτοπιο
ATE252640T1 (de) Verbindungen zur immunotherapie und diagnose von tuberkulose
JPH07285996A (ja) 抗原特異的活性化ｔリンパ球、その検出及び使用
ATE442439T1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
NZ332427A (en) Peptides suitable for use in antigen specific immunosuppressive therapy
ATE275968T1 (de) Mitteln zur behandlung von auto-immun krankheiten
DE69433115D1 (de) Verfahren zur isolierung von cda-präsentierten antigenen, cd1-präsentierte antigeneenthaltende impfstoffe und in besagten verfahren verwendbare zelllinien
ATE185151T1 (de) Neue peptide zur verwendung bei behandlung von durch t-zellen vermittelter knorpelzerstörungin autoimmunkrankheiten
TR200100175T2 (tr) Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.
Choudhury et al. Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool
Benacerraf Biological function of HLA molecules
Buus et al. The Interaction between MHC Class II Molecules and Immunogenic Peptides
Kennedy THE ROLE OF THE RT6 ALLOANTIGEN IN THE INDUCTION AND REGULATION OF TUBERCULIN DELAYED HYPERSENSITIVITY IN RATS (T-LYMPHOCYTES, SUBPOPULATIONS)